Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Hubalek, M; Buchner, H; Mörtl, MG; Schlembach, D; Huppertz, B; Firulovic, B; Köhler, W; Hafner, E; Dieplinger, B; Wildt, L; Dieplinger, H.
The vitamin E-binding protein afamin increases in maternal serum during pregnancy.
Clin Chim Acta. 2014; 434(5):41-47
Doi: 10.1016/j.cca.2014.03.036
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Huppertz Berthold
-
Mörtl Manfred Georg
-
Schlembach Dietmar
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Afamin is a liver-derived plasma glycoprotein with vitamin E-binding properties and a putative function in fertility. This study evaluated serum afamin concentrations during and postpartum to uncomplicated pregnancies and investigated a potential association between afamin concentrations and pregnancy outcome.
Afamin serum concentrations were measured in women with uncomplicated pregnancies in a retrospective cohort (n=466) at different gestational ages and a prospective observational study (n=76) in the first, second and third trimester. Furthermore, afamin was determined in the first trimester in a cross-sectional pilot study including women with preeclampsia (PE), pregnancy-induced hypertension (PIH) and women without pregnancy complications (n=13 each). Finally, expression of afamin was investigated in human placental tissue by RT-PCR and immunohistochemistry.
Afamin concentrations increased linearly almost two-fold during pregnancy in both retrospective and prospective studies in women without pregnancy complications with median afamin serum concentrations of 61.9 mg/l, 79.6 mg/l, and 98.6 mg/l in the first, second, and third trimester, respectively. After delivery, median afamin concentrations decreased to baseline values of 54.6 mg/l. In the pilot study with pregnancy complications, women with PE displayed significantly higher median afamin concentrations than did women with uncomplicated pregnancy (70.0 mg/l vs. 55.4 mg/l, P=0.007). Expression analyses revealed no placental afamin expression at either mRNA or protein level in uncomplicated pregnancy.
A linear increase in the maternally expressed glycoprotein afamin during pregnancy may serve as basic reference for subsequent investigations of afamin in pregnancy-related disorders.
Copyright © 2014. Published by Elsevier B.V.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult -
-
Carrier Proteins - blood
-
Cross-Sectional Studies -
-
Female -
-
Gene Expression Regulation - physiology
-
Glycoproteins - blood
-
Humans -
-
Pilot Projects -
-
Pre-Eclampsia - blood
-
Pre-Eclampsia - metabolism
-
Pregnancy -
-
Pregnancy Trimesters -
-
Retrospective Studies -
-
Serum Albumin -
-
Serum Albumin, Human -
-
Vitamin E - metabolism
-
Young Adult -
- Find related publications in this database (Keywords)
-
Afamin in pregnancy
-
maternal expression
-
pregnancy complications
-
preeclampsia